Overview

Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
To compare the rates of clinical success of Topical Dermacyn™ vs. Oral Levofloxacin vs. Combined therapy, in subjects with mild diabetic foot infections in non-ischemic ulcers.
Phase:
Phase 2
Details
Lead Sponsor:
Oculus Innovative Sciences, Inc.
Treatments:
Levofloxacin
Ofloxacin
Sodium Hypochlorite